thiazolyl blue has been researched along with Granulocytic Leukemia, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besra, SE; Bhattacharya, S; Das, M; Ghosh, P; Gomes, A; Majumdar, J; Mitra, S; Murmu, N; Sur, P; Vedasiromoni, JR | 1 |
| Emerson, SG; Gewirtz, AM; Kalota, A; Nakata, Y; Ptasznik, A | 1 |
| Efferth, T; Fabry, U; Glatte, P; Osieka, R | 1 |
| Bhattacharya, M; Bhattacharya, S; Biswas, J; Das, M; Ghosh, M; Ghosh, P; Gomes, A; Mitra, S; Murmu, N; Sur, P; Vedasiromoni, JR | 1 |
| Boyd, MR; Monks, A; Pittman, A; Scudiero, D; Skehan, P; Vistica, DT | 1 |
| Huismans, DR; Leyva, A; Pieters, R; Veerman, AJ | 1 |
6 other study(ies) available for thiazolyl blue and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Antineoplastic effect of new boron compounds against leukemic cell lines and cells from leukemic patients.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Boron Compounds; Cell Division; Guanidines; HL-60 Cells; Humans; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Tetrazolium Salts; Thiazoles; Thymidine; U937 Cells | 2002 |
Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.
Topics: Apoptosis; Blast Crisis; Blotting, Western; Fusion Proteins, bcr-abl; Humans; In Situ Nick-End Labeling; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; RNA Interference; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2004 |
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Boron compounds against human leukemic cells.
Topics: Apoptosis; Boron Compounds; Cell Division; DNA, Neoplasm; Guanidines; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Tetrazolium Salts; Thiazoles; Thymidine; Tumor Cells, Cultured; U937 Cells | 2001 |
Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
Topics: Carcinoma, Renal Cell; Cell Division; Cell Line; Cell Survival; Coloring Agents; Drug Screening Assays, Antitumor; Formazans; Glucose; Humans; Kidney Neoplasms; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; NAD; NADP; Tetrazolium Salts; Thiazoles | 1991 |
Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
Topics: Antineoplastic Agents; Cell Survival; Child; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1989 |